A vitamin-E-fortified diet reduces oxidative stress, sympathetic nerve activity, and hypertension in the phenol-renal injury model in rats

Journal of the American Society of Hypertension

Volumn 1, Issue 4, 2007, Pages 242-250

  Campese, Vito M ^a   Ye, Shaohua ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Hypertension; interleukin 1 ; nitric oxide; reactive oxygen species; renal injury; sympathetic nervous system; vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; NORADRENALIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL FOOD; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; BRAIN NUCLEUS; CONTROLLED STUDY; DNA SEQUENCE; DRUG EFFICACY; DRUG MECHANISM; HYPERTENSION; KIDNEY INJURY; MALE; NONHUMAN; NORADRENALIN RELEASE; NORADRENERGIC SYSTEM; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; POSTERIOR HYPOTHALAMUS; PRIORITY JOURNAL; RAT; SYMPATHETIC TONE;

EID: 34447634266     PISSN: 19331711     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jash.2007.04.003     Document Type: Article

References (37)

1. Ye S., Ozgur B., and Campese V.M. Renal afferent impulses, the posterior hypothalamus, and hypertension in rats with chronic renal failure. Kidney Int 51 (1997) 722-727
2. Ye S., Gumburd M., and Campese V.M. An acute renal injury may cause a permanent form of neurogenic hypertension. Am J Hypertens 11 (1998) 723-728
3. Ye S., Nosrati S., and Campese V.M. Nitric oxide (NO) modulates the neurogenic control of blood pressure in rats with chronic renal failure. J Clin Invest 99 (1997) 540-548
4. Ye S., Mozayeni P., Gamburd M., Zhong H., and Campese V.M. Interleukin-1β and neurogenic control of blood pressure in normal rats and rats with chronic renal failure. Am J Physiol 279 (2000) H2786-H2796
5. Nakazono K., Watanabe N., Matsuno K., Sasaki J., Sato T., and Inoue M. Does superoxide underlie the pathogenesis of hypertension?. Proc Natl Acad Sci U S A 88 (1991) 10045-10048
6. Vaziri N.D., Liang K., and Ding Y. Increased nitric oxide inactivation by reactive oxygen species in lead-induced hypertension. Kidney Int 56 (1999) 1492-1498
7. Kerr S., Brosnan J., McIntyre M., Reid J.L., Dominiczak A.F., and Hamilton C.A. Superoxide anion production is increased in a model of genetic hypertension. Role of the endothelium. Hypertension 33 (1999) 1353-1358
8. Schnackenberg C.G., and Wilcox C.S. Two-week administration of tempol attenuates both hypertension and renal excretion of 8-iso prostaglandin F2. Hypertension 33 (1999) 424-428
9. Campese V.M., Ye S., Zhong H., Yanamadala V., Ye Z., and Chiu J. Reactive oxygen species stimulate central and peripheral sympathetic nervous system activity. Am J Physiol Heart Circ Physiol 287 (2004) H695-H703
10. Lerman L.O., Nath K.A., Rodriguez-Porcel M., Krier J.D., Schwartz R.S., Napoli C., et al. Increased oxidative stress in experimental renovascular hypertension. Hypertension 27 (2001) 541-546
11. Gonick H.C., Cohen A.H., Ren Q., Saldanha L.F., Khalil-Manesh F., Anzalone J., et al. Effect of 2,3-dimercaptosuccinic acid on nephrosclerosis in the Dahl rat. I. Role of reactive oxygen species. Kidney Int 50 (1996) 1572-1582
12. Vaziri N.D., Ding Y., Ni Z., and Gonick H.C. Altered nitric oxide metabolism and increased oxygen free radical activity in lead-induced hypertension. Effect of lazaroid therapy. Kidney Int 52 (1997) 1042-1046
13. Vaziri N.D., Wang Z.Q., Oveisi F., and Rad B. Induction of oxidative stress by glutathione depletion causes hypertension in normal rats. Hypertension 36 (2000) 142-146
14. Zanziger J., and Czachurski J. Chronic oxidative stress in the RVLM modulates sympathetic control of circulation in pigs. Pflugers Arch 439 (2000) 489-494
15. Xu H., Fink G.D., and Galligan J.J. Nitric oxide independent effects of tempol on sympathetic nerve activity and blood pressure in DOCA-salt rats. Am J Physiol Heart Circ Physiol 283 (2002) H885-H892
16. Ye S.-H., Zhong H., and Campese V.M. Oxidative stress mediates the stimulation of sympathetic nerve activity in the phenol renal injury model of hypertension. Hypertension 48 (2006) 309-325
17. Bredt D.S., Hwang P.M., Glatt C.E., Lowenstein C., Reed R.R., and Snyder S.H. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature 351 (1991) 714-718
18. Scotte M., Hiron M., Masson S., Lyoumi S., Banine F., Te'niere P., et al. Differential expression of cytokine genes in monocytes, peritoneal macrophages and liver flowing endotoxin- or turpentine-induced inflammation in rat. Cytokine 8 (1996) 115-120
19. Higuchi R., and Dollinger G. Simultaneous amplification and detection of specific DNA sequences. Biotechnology 10 (1992) 413-417
20. Nakata T., Berard W., Kogosov E., and Alexander N. Microdialysis in the posterior hypothalamus: sodium chloride affects norepinephrine release, mean arterial pressure, heart rate and behaviors in awake rats. Brain Res Bull 25 (1990) 593-598
21. Kukreja R.C., and Hess M.L. The oxygen free radical system: from equations through membrane-protein interactions to cardiovascular injury and protection. Cardiovasc Res 26 (1992) 641-655
22. Howe C.J., LaHair M.M., and McCubrey J.A. Redox regulation of the calcium/calmodulin-dependent protein kinases. J Biol Chem 279 (2004) 44573-44581
23. Cai H., Davis M.E., Drummond G.R., and Harrison D.G. Induction of endothelial NO synthase by hydrogen peroxide via a Ca2+/calmodulin-dependent protein kinase II/janus kinase 2-dependent pathway. Arterioscler Thromb Vasc Biol 21 (2001) 1571-1576
24. Moskovitz J., Bar-Noy S., Williams W.M., Requena J., Berlett B.S., and Stadtman E.R. Methionine sulfoxide reductase (MsrA) is a regulator of antioxidant defense and lifespan in mammals. Proc Natl Acad Sci U S A 98 (2001) 12920-12925
25. Schnackenberg C.G., Welch W.J., and Wilcox C.S. Normalization of blood pressure and renal vascular resistance in SHR with a membrane-permeable superoxide dismutase mimetic: role of nitric oxide. Hypertension 32 (1998) 59-64
26. Suzuki H., DeLano F.A., Parks D.A., Jamshidi N., Granger D.N., et al. Xantine oxidase activity associated with arterial blood pressure in spontaneously hypertensive rats. Proc Natl Acad Sci U S A 95 (1998) 4754-4759
27. Swei A., Lacy F., Delano F.A., Parks D.A., and Schmid-Schonbein G.W. A mechanism of oxygen free radicals production in the Dahl hypertensive rat. Microcirculation 6 (1999) 179-187
28. Somers M.J., Mavromatis K., Galis Z.S., and Harrison D.G. Vascular superoxide production and vasomotor function in hypertension induced by deoxycorticosterone acetate-salt. Circulation 101 (2000) 1722-1728
29. Vaziri N.D., Oveisi F., and Ding Y. Role of increased oxygen free radical activity in the pathogenesis of uremic hypertension. Kidney Int 53 (1998) 1748-1754
30. Lopez-Ongil S., Hernandez-Perera O., Navarro-Antolin J., Perez de Lema G., Rodríguez-Puyol M., Lamas S., and Rodríguez-Puyol D. Role of reactive oxygen species in the signaling cascade of cyclosporine A-mediated up-regulation of eNOS in vascular endothelial cells. Br J Pharmacol 124 (1998) 447-454
31. Roggensack A.M., Zhang Y., and Davidge S.T. Evidence for peroxynitrate formation in the vasculature of women with pre-eclampsia. Hypertension 33 (1999) 83-89
32. Touyz R.M., Chen X., Tabet F., Yao G., He G., Quinn M.T., et al. Expression of a functionally active gp91-ohox-containing neutrophil-type NADPH oxidase in smooth muscle cells from human resistance arteries: regulation by angiotensin II. Circ Res 90 (2002) 1205-1213
33. Geiszt M., Kopp J.B., Varnai P., and Leto T.L. Identification of Renox, an NADPH oxidase in kidney. Proc Natl Acad Sci U S A 97 (2000) 8010-8014
34. Wilcox C.S., and Gutterman D. Focus on oxidative stress in the cardiovascular and renal systems. Am J Physiol Heart Circ Physiol 288 (2005) H3-H6
35. Chen X., Touyz R.M., Park J.B., and Schiffrin E.L. Antioxidant effects of vitamin C and E are associated with altered activation of vascular NADPH oxidase and superoxide dismutase in stroke-prone SHR. Hypertension 38 (2001) 606-611
36. Zhan C.D., Sindhu R.K., and Vaziri N.D. Up-regulation of kidney NADPH oxidase and calcineurin in SHR: reversal of lifelong antioxidant supplementation. Kidney Int 65 (2004) 219-227
37. Calvisi D.F., Ladu S., Hironaka K., Factor V.M., Thorgeirsson S.S., and Snorri S. Vitamin E down-modulates iNOS and NADPH oxidase in c-Myc-TGF-alpha transgenic mouse model in liver cancer. J Hepatol 41 (2004) 815-822